Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Engensis in painful diabetic peripheral neuropathy
NCT01002235Phase 2Completed
- Sponsor
- Helixmith
- Start
- Feb 2010
- Primary completion
- Apr 2011
- Modality
- Gene Editing, Gene Silencing, Plasmid DNA
- Countries
- 1
01
Overview
A Phase 2 trial of Engensis in diabetic peripheral neuropathy (DPN), sponsored by Helixmith. Started Feb 2010; status: completed.
02
Drugs
Engensis
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT01002235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01002235.